International medicine: Planned increase in fundraising not exceeding 1.08 billion yuan

International Medical Announcement: The company plans to issue stocks to specific investors in 2025 to raise funds not exceeding 1.008 billion yuan. After deducting issuance expenses, the funds will be used for the Smart Healthcare Project, Proton Therapy Center Phase II Project, and supplementary working capital. The Smart Healthcare Project is expected to require an investment of 0.751 billion yuan, with 0.638 billion yuan to be allocated from the raised funds; the Proton Therapy Center Phase II Project is expected to require an investment of 99.931 million yuan, with 99.931 million yuan to be allocated from the raised funds; and the supplementary working capital is 0.27 billion yuan. The total number of stocks to be issued this time will not exceed 672 million shares, with the issuance price not lower than 80% of the average trading price of the company's stock on the 20 trading days prior to the pricing benchmark date.